Pacific Biosciences of California Inc. buy Stephens
Start price
14.12.23
/
50%
€8.42
Target price
14.12.24
€10.05
Performance (%)
-76.65%
Price
26.07.24
€1.97
Summary
This prediction is currently active. The BUY prediction by Stephens for Pacific Biosciences of California Inc. is performing very badly with a performance of -76.65%. This prediction currently runs until 14.12.24. The prediction end date can be changed by Stephens at any time. Stephens has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | 29.249% | 29.249% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Stephens for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is now covered by analysts at Stephens. They set an "overweight" rating and a $11.00 price target on the stock.
Ratings data for PACB provided by MarketBeat